Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

GRCL Gracell Biotechnologies

3.220
+0.620+23.85%
Close 09/30 16:00 ET
3.2200.0000.00%
Post Mkt Price 09/30 16:00 ET
High
3.440
Open
2.540
Turnover
429.74K
Low
2.530
Pre Close
2.600
Volume
134.96K
Market Cap
217.91M
P/E(TTM)
Loss
52wk High
15.000
Shares
67.67M
P/E(Static)
Loss
52wk Low
1.680
Float Cap
77.30M
Bid/Ask %
-17.65%
Historical High
33.700
Shs Float
24.01M
Volume Ratio
4.38
Historical Low
1.680
Dividend TTM
--
Div Yield TTM
--
P/B
0.90
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.56%
Amplitude
35.00%
Avg Price
3.184
Lot Size
1
Float Cap
77.30M
Bid/Ask %
-17.65%
Historical High
33.700
Shs Float
24.01M
Volume Ratio
4.38
Historical Low
1.680
Dividend TTM
--
P/B
0.90
Dividend LFY
--
Turnover Ratio
0.56%
Amplitude
35.00%
Avg Price
3.184
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Gracell Biotechnologies, Inc. engages in the research and development activities of biotechnological and pharmaceutical industries. The firm through its FasTCAR and TruUCAR platforms, it is developing a pipeline of autologous and allogeneic cell therapy candidates with the potential to treat both hematologic malignancies and solid tumors. The company was founded by William Wei Cao in 2017 and is headquartered in Suzhou, China.
CEO: Dr. Wei William Cao, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...